Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The best smart home devices can raise your home's IQ, from security cameras and Wi-Fi locks to smart light bulbs. When you purchase through links on our site, we may earn an affiliate commission.

The Business Research Company's Insulin Pens, Syringes, Pumps And Injectors Global market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 You Can Now Pre Order Your Report To ...

We take a look at some of the exciting diabetes research developments announced in October, and what the findings could mean for people living with or affected by diabetes.

Smart lights are an easy way to save energy while adding a little flare to your home. Get started with CNET’s top picks. Originally hailing from Troy, Ohio, Ry Crist is a writer, a text-based ...

However, predicting how blood sugar will change is often tricky, and even a slight miscalculation in insulin dosage can lead to a dangerous condition known as hypoglycemia, where blood sugar drops ...

This is not only a sustainability consideration but also a patient safety issue as insulin that has been stored incorrectly may not have the expected effect on blood glucose. I have had type 1 ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...

Disposable pens appeal to cost-conscious users, while reusable pens provide long-term value. Furthermore, the introduction of smart insulin pens has revolutionized the market by integrating features ...

The first-of-its-kind study will be the first to evaluate closed-loop technology in people using Insulin Pens with Time-in-Range as a primary efficacy endpoint. SAN DIEGO, CA / ACCESSWIRE / October 23 ...